Brain magnetic resonance imaging biomarkers for future frailty; sub-study of FINGER trial

脑磁共振成像生物标志物与未来衰弱的关系;FINGER试验的子研究

阅读:2

Abstract

INTRODUCTION: Brain magnetic resonance imaging (MRI) biomarkers for dementia exist, but little is known about their association with future frailty. We investigated whether baseline brain MRI findings associate with pre-frailty/frailty over 11 years. METHODS: One hundred twenty participants, aged 60 to 77 years, in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) had baseline MRI data. Frailty status (Fried phenotype) was measured at baseline, and at 2, 7, and 11 years. Risk of future pre-frailty/frailty per one standard deviation or one class greater volume/thickness/Fazekas score in baseline MRI was evaluated. RESULTS: Pre-frailty/frailty was not associated with MRI biomarkers at baseline. Smaller left hippocampal volume was associated with pre-frailty/frailty at 2 (p = 0.042) and 7 years (p = 0.017), and higher load of periventricular white matter hyperintensities (WMHs) at 2 years (p = 0.048), independently of baseline cognition. DISCUSSION: Smaller left hippocampal volume and higher periventricular WMH score in brain MRI may indicate future frailty risk. CLINICAL TRIAL REGISTRATION NUMBER: The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) is registered at ClinicalTrials.gov (no. NCT01041989).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。